Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

ASML Receives Major Upgrade as Next-Generation Chip Technology Gains Momentum

Robert Sasse by Robert Sasse
November 8, 2025
in Analysis, European Markets, Semiconductors, Tech & Software
0
Asml Stock
0
SHARES
134
VIEWS
Share on FacebookShare on Twitter

ASML Holding NV, the Dutch semiconductor equipment manufacturer, received a significant vote of confidence from financial analysts on Friday. Investment bank Rothschild & Co Redburn elevated its rating on the company’s shares from “Neutral” to “Buy,” citing substantial untapped potential in the upcoming generation of chip manufacturing technology. This optimistic assessment coincides with ASML reinforcing its strategic position in the challenging Chinese market during the Industrial Expo in Shanghai.

Financial Projections Revised Upward

The analyst team at Rothschild has substantially increased its earnings forecasts for ASML, raising projections for the period between 2026 and 2030 by a notable 7 to 17 percent. This revised outlook places their estimates well above the current market consensus. Their financial model anticipates total revenue growing from €32.6 billion this year to €55.9 billion by 2030. A key driver of this growth is the High-NA Extreme Ultraviolet (EUV) lithography segment, which is projected to expand from €2.3 billion in 2026 to €6 billion in 2030.

High-NA EUV Technology: A Strategic Advantage

The core rationale behind the upgraded rating centers on ASML’s latest technological advancement: High-NA EUV lithography. Rothschild’s analysis highlights critical improvements in a process known as “Field Stitching,” which significantly enhances the technology’s appeal for mass production. The timing appears ideal, as the rising importance of chiplet architecture for artificial intelligence processors in data centers aligns perfectly with the inherent strengths of High-NA systems.

Furthermore, Rothschild anticipates that the proportion of lithography equipment within total wafer fab investment will climb to 23 percent by 2030. This trend was already foreshadowed by the robust order intake ASML reported in the third quarter.

Advertisement:

Should investors sell immediately? Or is it worth buying Asml?

A complimentary report details which Industry 4.0 stocks stand to benefit from increasing automation, robotics, and smart factory investments. Secure your free Industry 4.0 report now

China’s Enduring Strategic Role

Alongside the positive analyst action, ASML delivered clear messaging from the China International Import Expo in Shanghai. Vice President Shen Bo emphasized that China remains an indispensable component of the global semiconductor ecosystem. While the elevated revenue contribution from the past two years is expected to normalize, the company framed this not as a weakness but as a reflection of standard industry cycles.

ASML’s strategy demonstrates a dual focus: maintaining strong relationships with its Chinese customer base while simultaneously advancing its technological leadership. The demand base is also broadening, with industry giants Intel and Samsung joining as major clients for EUV technology.

TSMC: A Potential Catalyst for 2026

A pivotal event is already on the calendar for April 2026. Taiwan Semiconductor Manufacturing Co. (TSMC), ASML’s most significant customer, is scheduled to present its own High-NA technology roadmap at its Technology Symposium. Such an announcement would represent a definitive breakthrough for ASML. As the sole provider of this foundational technology, the company would be positioned for a substantial surge in demand.

Ad

Asml Stock: Buy or Sell?! New Asml Analysis from March 25 delivers the answer:

The latest Asml figures speak for themselves: Urgent action needed for Asml investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Asml: Buy or sell? Read more here...

Tags: ASML
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock
AI & Quantum Computing

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Next Post
Hertz Globalew Equity Warrants Stock

Hertz Warrants Surge on Stunning Corporate Reversal

Applovin Stock

AppLovin Shares Surge on AI-Powered Performance

Vulcan Energy Stock

Vulcan Energy Powers Europe's Lithium Independence Drive

Recommended

iRadimed Stock

iRadimed: Record Performance Meets Divergent Institutional Strategies

7 months ago
Alphabet Stock

Alphabet Shares Under Scrutiny as CEO Pichai Executes Multi-Million Dollar Stock Sale

6 months ago
Bloom Energy Stock

Bloom Energy Shares Plunge Following Spectacular Rally

4 months ago
Strategy Stock

Strategy Shares Plunge Following Dual Capital Raise Announcement

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

Trending

Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

by SiterGedge
March 25, 2026
0

As Humacyte prepares to release its full-year 2025 financial results, the biotechnology firm finds its stock trading...

Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com